McNulty James A's Form 4 filing
Inhibitor Therapeutics, Inc. (INTI) · filed Aug 4, 2026
- Accession no.
- 0001493152-26-036080
- Filed
- Aug 4, 2026, 9:03 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 34 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 34 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McNulty James ACIK 0001275857 | Officer (Chief Financial Officer) |
| Black Robe Capital LLCCIK 0001977553 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | GGiftDisposed | −3,200,000 | $0.00 | $0 | 19,901,057 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.